Citation Impact
Citing Papers
Phenotypic and functional features of human Th17 cells
2007 Standout
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation
2003 Standout
CTLA-4-Mediated Inhibition of Early Events of T Cell Proliferation
1999 StandoutNobel
Spontaneous Large-Scale Lymphoid Neogenesis and Balanced Autoimmunity versus Tolerance in the Stomach of H+/K+-ATPase-Reactive TCR Transgenic Mouse
2006 StandoutNobel
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
Functional diversity of helper T lymphocytes
1996 StandoutNature
Adhesion molecules in rheumatoid arthritis
1998
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system
2003
Immunohistochemical analysis of hip arthritis in ankylosing spondylitis: Evaluation of the bone–cartilage interface and subchondral bone marrow
2006
Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo‐controlled trial (ASSERT)
2005
Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H‐2Ab allele on the response to allo‐4‐hydroxyphenylpyruvate dioxygenase
1995
The role of IL-12 in the induction of organ-specific autoimmune diseases
1995
Rheumatoid arthritis
2016 Standout
Analysing chronic spinal changes in ankylosing spondylitis: a systematic comparison of conventional x rays with magnetic resonance imaging using established and new scoring systems
2004
Th1/Th2 Cells
1999
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
Interleukin-12 and the regulation of innate resistance and adaptive immunity
2003 Standout
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain
2003 StandoutNature
Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor α in two patients with early disease and transforming growth factor β in three more advanced cases
2005
Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen‐induced arthritis
1996
Animal models of inflammatory spinal and sacroiliac joint diseases
2003
Juvenile idiopathic arthritis
2007 Standout
Monoclonal anti‐TNFα Antibody as a Probe of Pathogenesis and Therapy of Rheumatoid Disease
1995
Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis— cellularity correlates with the degree of enhancement detected by magnetic resonance imaging
2000
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?
2000
Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis
2004 Standout
Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: A register study
2001
Human cartilage glycoprotein‐39 as a candidate autoantigen in rheumatoid arthritis
1997
Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial
2006
T helper type 2 like cytokine responses to peptides from P0 and P2 myelin proteins during the recovery phase of Guillain-Barré syndrome
1997
Vaccination against Lyme Disease with RecombinantBorrelia burgdorferiOuter-Surface Lipoprotein A with Adjuvant
1998 Standout
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Pathogenesis of spondylarthropathies
1995
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis
2000
Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy
2005
Enhancement of endotoxin‐induced interleukin‐10 production by SR 31747A, a sigma ligand
1995
T Cell–Mediated Elimination of B7.2 Transgenic B Cells
1997 StandoutNobel
Ankylosing spondylitis
2007 Standout
First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
2005
How important are T cells in chronic rheumatoid synovitis?: II. T cell‐independent mechanisms from beginning to end
2002
Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis
1997
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis
2003
Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin‐10 and interleukin‐4
1996
Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial
2002 Standout
Selective inhibition of NF-κB blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo
2004 Standout
Rheumatic diseases: the effects of inflammation on bone
2005
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Predominant cellular immune response to the cartilage autoantigenic G1 aggrecan in ankylosing spondylitis and rheumatoid arthritis
2003
HLA–B27–restricted CD8+ T cell response to cartilage‐derived self peptides in ankylosing spondylitis
2005
Interleukin-23 Promotes a Distinct CD4 T Cell Activation State Characterized by the Production of Interleukin-17
2003 Standout
Idiopathic Pulmonary Fibrosis
2001 Standout
Pro-and Anti-inflammatory Cytokines in Rheumatoid Arthritis
1997
Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
2000
High level of interleukin‐10 production by the activated t cell population within the rheumatoid synovial membrane
1995
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-? antagonists
2007
Cytokine gene polymorphisms relevant for the spondyloarthropathies
2001
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological Synapse
2004 StandoutNobel
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
2002 StandoutNature
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
1999
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial
2003
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
2004
Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion
2002
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Analysis of the CD8+ T cell response to the G1 domain of aggrecan in ankylosing spondylitis
2004
Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α
2002
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
1995
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: Results of a multicenter, randomized, double‐blind, placebo‐controlled magnetic resonance imaging study
2006
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System
2005 Standout
Guillain-Barré syndrome
2005 Standout
RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES
1998
IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines
2005 Standout
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1
2001 Standout
The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis.
1994
An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease
1998
Selective Expression and Functions of Interleukin 18 Receptor on T Helper (Th) Type 1 but not Th2 Cells
1998
T‐cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man
2012 StandoutNobel
Local Immune Responses to Chlamydia pneumoniae in the Lungs of BALB/c Mice during Primary Infection and Reinfection
1998
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
2005 Standout
Production of T-cell cytokines at the single-cell level in patients with inflammatory arthritides: enhanced activity in synovial fluid compared to blood
1998
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice
2002 StandoutNobel
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Lymphoid neogenesis:de novoformation of lymphoid tissue in chronic inflammation through expression of homing chemokines
2001
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
1997 Standout
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
CELLULAR RESPONSES TO INTERFERON-γ
1997 Standout
Th1/Th2 cells
2007
Immunobiology of Dendritic Cells
2000 Standout
Regulation of Interleukin (IL)-12 Receptor β2 Subunit Expression by Endogenous IL-12: A Critical Step in the Differentiation of Pathogenic Autoreactive T Cells
1999
Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4.
1995
TNF‐mediated inflammatory disease
2007 Standout
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell–mediated spontaneous autoimmune arthritis in mice
2004 StandoutNobel
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
1996
Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease.
2003
Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells
1998
Interleukin‐17: the missing link between T‐cell accumulation and effector cell actions in rheumatoid arthritis?
2004
Free Radicals in the Physiological Control of Cell Function
2002 Standout
IL-17 Is Produced by Some Proinflammatory Th1/Th0 Cells But Not by Th2 Cells
1999
Works of Eva Seipelt being referenced
Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis
1995
Divergent T-cell cytokine patterns in inflammatory arthritis.
1994
Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset
1993